# BPC-157 for a herniated disc: what the evidence reaches, and what it does not

slug: bpc-157-herniated-disc · https://miscsubjects.com/a/bpc-157-herniated-disc · tags: peptide, bpc-157, herniated-disc, spine, pairing · updated 2026-08-04T20:48:58.174Z

BPC-157 is a 15-amino-acid chain copied from a sequence found in human stomach juice, sold as a freeze-dried powder for injection or as an oral tablet. Nobody has ever given it to a person with a herniated disc under any kind of controlled test, in any country, and the animal work that exists was done on tendon, muscle, ligament and cut nerve — never on a disc.

That second sentence is the whole shape of the decision, and it is not the same thing as "it does nothing". What follows is the evidence that exists, strongest kind first, the arithmetic for a dose, the legal position on 4 August 2026, and a count of what twenty-four people with a spine problem said happened to them.

The site that publishes this page has a commercial relationship with a seller of this compound. Treat that as a reason to open every source link below rather than a reason to trust the summary.

## Seven in ten of these clear on their own, and that is the number anything has to beat

Before any compound: a meta-analysis pooled 31 studies covering 2,233 people whose herniated discs were managed without surgery. The displaced disc material was reabsorbed in 70.39% of them. The rate ran 87.77% where a fragment had fully broken free, 66.91% for an extrusion, 37.53% for a protrusion, 13.33% for a bulge. Most of the shrinking happened inside the first six months.

[[embed:source:s26]]

And a randomised trial in 283 people with severe leg pain lasting 6 to 12 weeks compared early surgery against continued conservative care. Surgery took the leg pain away faster. At one year, the probability of feeling recovered was 95% in both arms.

[[embed:source:s27]]

Hold those two numbers against everything below. If you start a compound today and feel better in three months, the honest reading is that you are inside the seven-in-ten who were going to improve anyway. Nothing on this page separates you from that group, because no trial has ever been run that could.

[[embed:herniated-disc]]

## Your problem is at least three problems, and a compound can only reach two of them

The first is space. Disc material is sitting where a nerve root needs to be. That is what the scan measures, and the only two things that remove it are your own body digesting the fragment over months and a surgeon cutting it out. No compound in any species has been shown to shrink a herniation.

The second is chemistry. The material that leaked out is not inert. Mice given disc material placed against a nerve root developed lasting leg pain and damage to the nerve cells, with no squeezing involved at all — the inflammatory signal did it.

[[embed:source:s7]]

The inflammatory enzyme measured in human herniated disc material runs 20 to 100,000 times more active than the same enzyme measured from any other source in the literature.

[[embed:source:s8]]

The third is the nerve itself. A root that has been squeezed and chemically burned for weeks has damaged fibres, and that is what produces the numbness, the pins and needles and the weak foot. Nerve fibres regrow at roughly a millimetre a day, which is why that part of the recovery lags the pain by months.

The claim on the table is that this compound reaches the second and third problems and not the first. Read the next two sections deciding whether the animal work supports even that much.

## Nobody has put this compound near a spinal disc, in any species

A systematic review in orthopaedic sports medicine screened 544 articles from 1993 to 2024 and kept 36 studies. Thirty-five were animal or dish work. One was clinical. The tissues were muscle, tendon, ligament and bone.

[[embed:source:s11]]

There is no disc study. Not a rat disc, not a rabbit disc, not a disc in a dish. The tissue that is actually causing your pain has never been exposed to this compound in a published experiment. Every argument for using it on a disc is an argument by analogy from a different tissue, and analogies from tendon to disc are weak: a tendon has a blood supply and a disc, after about age twenty, has almost none.

## What the rats did show, and which of your three problems it lands on

Rat Achilles tendon torn off the bone. Treated animals healed with more strength at the tendon-to-bone join, and the same experiment showed a steroid drug made healing worse while the compound cut that damage back.

[[embed:source:w_59xoi0m3]]

Rat ligament cut through. Better function, better mechanical strength, better tissue on the slide, at both a microgram and a nanogram dose.

[[embed:source:w_ccsq5zep]]

Rat sciatic nerve cut and repaired. The nerve regrew faster and the leg worked better than in untreated animals. This is the single finding on this page that touches nerve tissue, and it is a cut nerve trunk in a rat leg, not a chemically inflamed nerve root in a human spine.

[[embed:source:w_032xvatb]]

Rat spinal cord crushed. Treated animals recovered movement, starting at the tail, and held it out to a year.

[[embed:source:s127]]

Tendon cells in a dish moved to the wound edge faster as the dose went up, and made more of the receptor that growth hormone docks into.

[[embed:source:w_ud0jx8hb]]

[[embed:source:w_y4s15wvm]]

Map that onto your three problems. Space: nothing, in any of it. Chemistry: the nerve and cord work is consistent with the inflamed-nerve part of your pain, in rodents. Structure: the tendon and ligament work is about a tissue you also injured, because a herniation almost always comes with a torn ring and months of guarding, but it is not about the disc.

## The steroid shot you probably already had is the strongest single link here

Most people arrive at this question having already had an epidural or a joint steroid injection, or a course of an anti-inflammatory tablet. Two separate rat studies found a corticosteroid made healing worse in tendon and in muscle, and that this compound reversed that damage. In the muscle study the reversal was described as complete.

[[embed:source:w_gttxaz57]]

And in a rat model of anti-inflammatory drug poisoning, diclofenac at 12.5 mg/kg for three days wrecked the stomach, gut and liver and progressed to brain swelling. The compound blocked that whole cascade, given either by injection or dissolved in the drinking water, at both 10 µg/kg and 10 ng/kg.

[[embed:source:w_odtbasyy]]

Read that carefully. It is a protection finding about the drugs you are already taking, not evidence that the combination heals a disc faster. What it does settle is that the medicine most likely to already be in your system is not, in rats, a documented conflict.

## Fifteen minutes in the blood, which is what decides the schedule

The only measurements of what a body does with this compound come from rats and beagles. Average time to clear half of it: 15.2 minutes. Into a vein in dogs: 5.27 minutes. Peak in the blood three minutes after an injection into muscle. The fraction reaching the blood after an injection into muscle was 14–19% in rats and 45–51% in dogs.

[[embed:source:w_n7ahbrni]]

Two things follow for a daily plan. A compound gone that fast is not working by holding a level in your blood, so splitting a daily dose beats taking it all at once, and a once-weekly schedule has no argument behind it. None of these numbers has ever been measured in a person.

## Turning a 10 mg vial into a number of marks on a barrel

The powder arrives sealed. You add bacteriostatic water — sterile water with 0.9% benzyl alcohol in it, which is the preservative that lets you put a needle back into the same vial for weeks. Plain sterile water dissolves it fine but makes the vial a one-time proposition.

The measuring device is a U-100 insulin syringe: 100 marks to a millilitre, so one mark is 0.01 mL. Two lines give you every conversion.

- Micrograms per mL = micrograms in the vial ÷ mL of water added.
- Micrograms per mark = that number ÷ 100.

A 10 mg vial holds 10,000 mcg. Add 3 mL and you have 3,333 mcg/mL, which is 33.3 mcg per mark. A 250 mcg dose is 250 ÷ 33.3 = 7.5 marks.

| Vial | Water added | Strength | Mcg per mark | Marks for 250 mcg | Marks for 500 mcg | Days at 500 mcg split into two |
|---|---|---|---|---|---|---|
| 5 mg | 2.0 mL | 2,500 mcg/mL | 25 | 10 | 20 | 10 |
| 5 mg | 2.5 mL | 2,000 mcg/mL | 20 | 12.5 | 25 | 10 |
| 10 mg | 2.0 mL | 5,000 mcg/mL | 50 | 5 | 10 | 20 |
| 10 mg | 3.0 mL | 3,333 mcg/mL | 33.3 | 7.5 | 15 | 20 |
| 10 mg | 5.0 mL | 2,000 mcg/mL | 20 | 12.5 | 25 | 20 |

Adding more water does not add or remove peptide. It only changes how many marks carry a given dose. Below about five marks per dose, misreading the barrel starts to matter more than the dose does, which is the argument for putting 3 mL rather than 2 mL into a 10 mg vial.

Once mixed and kept at 2–8 °C, the vial has about four weeks in it, and that limit comes from the preservative rather than the peptide. Do not shake it and do not freeze it after mixing — both tear the peptide chains apart and make them clump, and clumping is exactly the trigger FDA named for the immune system reacting to an injected peptide.

## Where the needle goes was never answered by the animal work

Every rat study injected either into the belly cavity or into a muscle far from the injury, and the healing still showed up at the wound. Nobody ran the experiment that compares injecting at the site against injecting anywhere else. So the widespread instruction to inject next to your spine rests on nothing published, and the people in the counted record below who got results injecting into a thigh or a glute are evidence against it mattering much.

## Where it stands legally, checked 4 August 2026

FDA placed the compound in the bulk-substance bucket flagged for significant safety risk, which is what stopped compounding pharmacies from making it.

[[embed:source:w_ghpbaz64]]

On 23 July 2026 the agency's own Pharmacy Compounding Advisory Committee voted against that position: eight yes, six no, one abstention. Reporting on the meeting noted that most of the yes votes came from members with peptide-industry ties. An advisory vote changes no rule by itself.

[[embed:source:w_38qd7eam]]

[[embed:source:s129]]

[[embed:source:w_lkfuwkh8]]

It is on the 2026 World Anti-Doping Agency prohibited list, in the class covering substances with no approval for human use, banned at all times in and out of competition.

[[embed:source:w_u19qrezt]]

[[embed:source:w_af5ht9pr]]

The only registered trial with a person and an injury in it is a Phase 2 study in acute hamstring strain, which is muscle, not disc, and had not reported when this page was checked.

[[embed:source:s6]]

The one safety measurement in people is a pilot infusion of up to 20 mg into a vein in two healthy adults, with no adverse effects recorded. Two people is a safety signal about a single infusion, not about eight weeks of daily injection.

[[embed:source:s3]]

## Twenty-four people with a spine problem said what happened, and here is the count

Method: searched old.reddit.com for "bpc 157 herniated disc", "bpc 157 sciatica" and "bpc157 disc bulge", read 18 threads in full, pulled 113 comments that name the compound, and kept the ones where a named account described their own lumbar or cervical spine problem and what happened. Twenty-four had a stated outcome. Two more had started too recently to count. That is the denominator; everything else in those threads was sourcing questions, dosing questions and injuries in other body parts.

**Sixteen said it helped.** The most detailed is an L5/S1 herniation treated with about 600 mcg a day for two and a half months, injected into the upper glute rather than the back, with no physical therapy at all — pain-free at the one-year mark, with the caveat added later that a nerve sensation in the leg came back after returning to Muay Thai, and "spinal discs require a good amount of time to fully heal."

Speed varied wildly. One person with L3–L5 bulging discs on 250 mcg of the compound plus 250 mcg of TB-500 twice a day wrote on day five that "the chronic pain is melting away, as of day three." Another, six years into an L4/L5 herniation with leg pain, reported at four days that a four-hour drive produced no pain for the first time. At the other end, one person with seven herniated discs wrote at 32 days that they had not felt this much relief in years, and another took eighteen months to recover without surgery while also doing physical therapy and taking collagen.

Almost every one of the sixteen was doing something else at the same time. TB-500 in most of them, physical therapy in several, a steroid injection in one, gabapentin in one, red-light therapy in one, weight loss in one. Three were reporting after surgery — one after a microdiscectomy that left them with a dropped foot, who wrote that five weeks of the pair "healed me". None of the sixteen is a clean read on this compound alone.

**Two said it worked and then stopped working when they stopped taking it.** One: six weeks of it "lowered the inflammation enough for life to be manageable. I was able to lift weights and stuff again. A week after running out of BPC-157 the pain came back completely. If not worse than before." The other finished a twelve-week run and found the pain returned, though not to where it had been.

That pattern is worth more attention than any of the enthusiastic reports, because it is what you would expect from something quieting inflammation around an irritated nerve rather than repairing anything. Relief that ends with the injections is relief, not repair.

**Five said nothing happened.** One with an L5/S1 herniation since age eighteen injected into their own back for three months and "couldn't tell you that it made any difference." One with an L3/4 bulge and an L5/S1 herniation ran the compound at 250 mcg a day with 5 mg of TB-500 a week for six weeks and had "zero noticeable difference in back pain over 6 weeks" — a dose at the bottom of the common range, which is the obvious objection to that one. One with two bulging discs tried it on several separate occasions and it did not help. One never injected anywhere near the back and said it did not do much. One said they noticed nothing and wondered aloud whether they had run it long enough.

**One got worse, in a specific and checkable way.** Two weeks in, their prescription pain medication stopped working. They stopped the compound and the medication started working again within 24 to 36 hours. That is a reported interaction with an opioid painkiller, from one person, uncontrolled, and it is the only harm report in the set that is about the spine problem rather than about the compound in general.

One further account belongs here and is not in the count. A person with multiple herniated discs from a car crash, with a graduate degree in kinesiology, who had taken this compound for other injuries, attributed her own recovery to a different peptide entirely and argued that this one "primarily targets soft tissue and ligament repair, which may be less directly effective in regenerating the disc structure itself." That is the same objection the missing disc study raises, made by someone who used the compound and did not credit it.

**What the count settles and what it does not.** Sixteen out of twenty-four is a high hit rate, and it is also exactly what you would get from a condition where seven in ten people improve without doing anything, in a population that self-selected by buying an expensive compound and posting about it. Nobody posts a thread called "I bought it and nothing happened", which is why the five negatives matter more than their share suggests. The two relapse reports are the most informative thing in the whole set, and no trial exists that would resolve them.

## What would have to change for any of this to be settled

One rat study putting the compound near a damaged disc would tell you whether the analogy from tendon holds. One trial randomising people with a confirmed extrusion to the compound or a placebo, measuring leg pain at six weeks and the fragment on a scan at six months, would separate it from the 70% who resorb anyway. Neither exists, neither is registered, and the only trial running is in hamstrings.

[[embed:bpc-157]]

[[embed:ara-290-herniated-disc]]

[[embed:tb-500-herniated-disc]]

[[embed:wolverine-stack]]


## Sources

1. Incidence of Spontaneous Resorption of Lumbar Disc Herniation: A Meta-analysis (Clin Spine Surg 2024, PMID 37559207) — https://pubmed.ncbi.nlm.nih.gov/37559207/
2. Surgery versus prolonged conservative treatment for sciatica (NEJM 2007, PMID 17538084) — https://pubmed.ncbi.nlm.nih.gov/17538084/
3. TNF-alpha in the nucleus pulposus mediates radicular pain in mice — https://pubmed.ncbi.nlm.nih.gov/18670336/
4. High levels of inflammatory phospholipase A2 activity in lumbar disc herniations — https://pubmed.ncbi.nlm.nih.gov/2218714/
5. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review — https://pubmed.ncbi.nlm.nih.gov/40756949/
6. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation — https://pubmed.ncbi.nlm.nih.gov/16583442/
7. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat — https://pubmed.ncbi.nlm.nih.gov/20225319/
8. Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury — https://pubmed.ncbi.nlm.nih.gov/19903499/
9. BPC 157 improves the healing course of spinal cord injury and leads to functional recovery in rats — https://pmc.ncbi.nlm.nih.gov/articles/PMC6604284/
10. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration — https://pubmed.ncbi.nlm.nih.gov/21030672/
11. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts — https://pmc.ncbi.nlm.nih.gov/articles/PMC6271067/
12. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application — https://pubmed.ncbi.nlm.nih.gov/20190676/
13. Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions — https://pubmed.ncbi.nlm.nih.gov/21295044/
14. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs — https://pmc.ncbi.nlm.nih.gov/articles/PMC9794587/
15. Bulk drug substances nominated for use in compounding under section 503A of the Federal Food, Drug, and Cosmetic Act — https://www.fda.gov/media/94155/download
16. July 23-24, 2026: meeting of the Pharmacy Compounding Advisory Committee — https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
17. An FDA Committee Just Voted in Favor of Peptides-Despite the Agency's Opposition (TIME) — https://time.com/article/2026/07/23/fda-committee-peptides/
18. FDA advisory panel narrowly votes to allow compounding of unapproved peptides — https://www.statnews.com/2026/07/23/fda-panel-okays-peptides-compound-pharmacies-bpc-157-kpv/
19. World Anti-Doping Code International Standard: Prohibited List 2026 — https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf
20. BPC-157: experimental peptide creates risk for athletes — https://www.usada.org/spirit-of-sport/bpc-157-peptide-prohibited/
21. BPC 157 for Acute Hamstring Muscle Strain Repair — https://clinicaltrials.gov/study/NCT07437547
22. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study — https://pubmed.ncbi.nlm.nih.gov/40131143/
23. Healing a herniated disc and severe sciatica pain (r/Sciatica) — https://old.reddit.com/r/Sciatica/comments/1bu215m/healing_a_herniated_disc_and_severe_sciatica_pain/
24. Peptides for lower back pain recovery (r/backpain) — https://old.reddit.com/r/backpain/comments/14iol96/peptides_for_lower_back_pain_recovery/
25. I took BPC-157 for 6 weeks after struggling with disc herniation (r/bpc_157) — https://old.reddit.com/r/bpc_157/comments/1gjuas9/i_have_sciatica_from_a_bulged_disc_and_it_has/no45zaf/
26. I tried both TB-500/BPC-157 together for L3/4 bulge and L5/S1 herniation (r/Biohacking) — https://old.reddit.com/r/Biohacking/comments/1rj45d2/bpc157_for_lower_back_pain/o8aqhiq/
27. 43 yo, L5/S1 herniated disc since I was 18 (r/Biohackers) — https://old.reddit.com/r/Biohackers/comments/1fvf89s/been_struggling_with_2x_herniated_discs_for_over/lq8f8jp/
28. BPC-157 blunted a prescription painkiller (r/Biohacking) — https://old.reddit.com/r/Biohacking/comments/1rj45d2/bpc157_for_lower_back_pain/
29. Multiple herniated discs after a rear-end crash (r/bpc_157) — https://old.reddit.com/r/bpc_157/comments/1foo6q0/bpc_157_to_aid_herniated_discs/losyqg1/


---

# Herniated disc: 70% resorb without surgery and 95% recover at one year

slug: herniated-disc · https://miscsubjects.com/a/herniated-disc · tags: condition, herniated-disc, sciatica, spine, disc · updated 2026-08-04T20:48:43.175Z

Start with the two numbers that should govern every decision you make about this in the next twelve months.

**Roughly seven out of ten herniated discs shrink and disappear on their own.** A meta-analysis pooled 31 studies covering 2,233 people treated without surgery: the disc material was reabsorbed in 70.39% of them overall. Broken down by how far the disc had pushed out — 87.77% for a fragment that had fully broken free, 66.91% for an extrusion, 37.53% for a protrusion, 13.33% for a bulge. Most of it happened inside the first six months.

[[embed:source:s26]]

**Roughly nineteen out of twenty people are recovered at one year, whichever route they take.** A randomised trial assigned 283 people with severe sciatica lasting 6 to 12 weeks to either early surgery or continued conservative care with surgery only if needed. Surgery relieved leg pain faster and produced faster perceived recovery. But at one year, the probability of perceived recovery was **95% in both groups**.

[[embed:source:s27]]

Hold those two numbers up against every claim anyone makes to you about a treatment for this — including every claim on this page. Seven in ten discs shrink on their own. Nineteen in twenty people are recovered at a year. Anything sold to you has to beat that baseline, or it has to be honest that it is buying you speed and comfort inside a recovery that was going to happen anyway.

## Before anything else: the symptoms that mean go now, not next week

These override everything below. Get to an emergency department immediately if you have:

- **Loss of bladder or bowel control**, or new difficulty starting or stopping urination
- **Numbness in the saddle area** — groin, buttocks, inner thighs, the parts that would contact a bicycle seat
- **Leg weakness that is getting worse day by day**, especially in both legs
- **Sudden loss of sexual sensation**

These can mean the nerve bundle at the base of the spine is being crushed. The window for preventing permanent damage is measured in hours, and the risk rises sharply past roughly 48 hours.

[[embed:source:s17]]

That is the whole exception list. If none of those apply, the rest of this page is about the ordinary case, and the ordinary case behaves far better than the diagnosis sounds.

## What actually happened inside your back

The disc between two bones of your spine is a fibre-wound ring with a pressurised, water-rich core. Under load, the core pushes outward and the ring contains it.

A herniation is the core (*nucleus pulposus*) pushing out through a crack in the ring (*annulus fibrosus*), almost always toward the back and to one side, because that is where the ring is thinnest and where a nerve root happens to be sitting.

[[embed:source:s1]]

The key word is **displaced**. Nothing was destroyed, nothing was severed, nothing was worn away. Living tissue moved from where it belongs to where it does not. That single distinction is why the 70% number exists — your body has a well-documented mechanism for removing tissue that is in the wrong place, and no mechanism at all for regrowing tissue that is gone.

Worth knowing before you read your report again: in people with **no back pain at all**, 29% of 20-year-olds and 43% of 80-year-olds have a disc protrusion on their scan. A true extrusion is rarer — in one study of 98 pain-free people, 27% had a protrusion and only 1% had an extrusion.

[[embed:source:s28]]

[[embed:source:s29]]

So a protrusion on your report may or may not be the thing hurting you. An extrusion that matches your symptom pattern almost certainly is.

## Your pain is four separate problems wearing one name

This is the most useful reframe on the page, because each of the four responds to different things, on different timescales, and only one of them is what the MRI is measuring.

**Layer 1 — Physical pressure.** Disc material is occupying space a nerve root needs. This is what the scan shows and what surgery removes.

**Layer 2 — Chemical irritation.** The material leaking out is not inert. It carries inflammatory signals that inflame the nerve directly, with no compression required.

**Layer 3 — Nerve fibre damage.** A nerve root that has been squeezed and chemically inflamed for weeks has damaged fibres. That is what produces the numbness, the pins and needles, and the weakness — and it recovers on nerve-repair timescales, which are slower than everything else here.

**Layer 4 — The surrounding tissue.** The torn ring, the segment that now moves differently, the muscles that have been guarding for months, and the movement patterns you have built around the pain.

Now the honest part, up front: **no compound, supplement, injection or peptide has been shown to reduce Layer 1.** The only two things that reduce physical pressure on the nerve are your own body reabsorbing the fragment over months, and a surgeon removing it. Anyone offering you a substance that shrinks a herniation is claiming something no study in any species supports. Everything else on this page is aimed at Layers 2, 3 and 4 — which, as it happens, is where most of your pain is coming from.

## Why a small herniation can hurt more than a large one

Here is the fact that explains why the imaging so often fails to match how you feel. Sciatica is largely chemical.

The core material carries TNF-alpha, which by itself produces nerve pain and nerve damage in controlled animal work — the compression is not required for the pain.

[[embed:source:s7]]

And it is loaded with an inflammatory enzyme called phospholipase A2, measured in herniated human discs at **20 to 100,000 times the activity of any other source described in the literature**.

[[embed:source:s8]]

Read that magnitude again. Displaced disc material is, chemically, one of the most inflammatory substances your body can put next to a nerve.

Two consequences fall out of it directly:

1. **Pain size does not track herniation size.** A small tear that leaks a lot of chemically active material next to an irritable nerve can hurt more than a large fragment sitting in a roomy space.
2. **Your pain will usually ease long before your scan changes.** The chemical irritation settles in weeks. The fragment shrinks over months. People routinely feel fine while the imaging still looks alarming, which is one good reason not to re-scan a recovering back.

## The counterintuitive rule: the worse it looks, the better it clears

Intuition says the big extruded fragment is catastrophic and the small contained bulge is minor. The resorption data says the reverse, and the gradient is steep:

| What the report says | Chance it reabsorbs |
|---|---|
| Sequestration — a fragment fully broken free | 87.8% |
| Extrusion — pushed out past the ring | 66.9% |
| Protrusion — bulging but still contained | 37.5% |
| Bulge — the whole rim extends outward | 13.3% |

[[embed:source:s26]]

A separate systematic review of predictive factors reaches the same conclusion: extruded and sequestered fragments are significantly more likely to regress completely than contained ones.

[[embed:source:s3]]

The mechanism explains the gradient exactly. Read the next section and the table stops being surprising.

## The removal mechanism runs on inflammation and blood supply — which is why it works better the further out the fragment is

The inside of a healthy disc is one of the few places in your body the immune system never visits. It has no blood supply and no immune surveillance. When core material breaks out through the ring, it enters a completely different neighbourhood: one with blood vessels, oxygen, and white blood cells that have never encountered this tissue before and treat it as foreign.

What happens next is a cleanup operation. Immune cells called macrophages swarm the fragment and digest it. New blood vessels grow into the edge of the fragment to supply the operation.

[[embed:source:s5]]

That new vessel growth at the fragment's rim is described as the principal driver of resorption, and it runs on VEGF, the body's main vessel-growth signal.

[[embed:source:s6]]

Now the gradient makes sense. **The more completely the fragment has broken out of the disc, the more of its surface is exposed to the cleanup crew.** A sequestered fragment is fully surrounded and clears 87.8% of the time. A contained bulge is still sealed inside the ring, invisible to the immune system, and clears 13.3% of the time. Exposure is the variable.

This has a direct and uncomfortable implication for treatment, taken up two sections below.

## What genuinely speeds recovery, ranked by the evidence behind it

**1. Keep moving. Do not go to bed.** Staying active beats bed rest for acute low back pain and sciatica — bed rest slows recovery rather than protecting it.

[[embed:source:s18]]

**2. Structured exercise, once you can tolerate it.** Cochrane pooled 249 randomised trials of exercise for chronic low back pain: a 15.2-point reduction on a 0–100 pain scale against no treatment, usual care or placebo, which clears the review's own pre-set threshold for a clinically important difference. No single style of exercise won. Doing it is what mattered.

[[embed:source:s30]]

**3. If you have a directional preference, use it.** Some people find one specific direction of movement — usually leaning backwards — pulls the pain out of the leg and back toward the spine. That migration of pain toward the centre is a good sign, and in the subgroup that shows it, the McKenzie approach of repeated end-range movements outperformed other exercise.

[[embed:source:s19]]

**4. Walk, once the acute stage passes.** In 701 adults randomised after recovering from an episode of back pain, a progressive individualised walking programme pushed the median time to the next activity-limiting episode from 112 days to 208 days, hazard ratio 0.72.

[[embed:source:s31]]

**5. Stop smoking.** Nicotine narrows the small vessels feeding a disc that already has the slowest nutrient delivery of any tissue in your body, and is directly toxic to disc cells. In 5,333 patients tracked through spinal care, the group who kept smoking showed no clinically important improvement in pain across an entire course of care.

[[embed:source:s24]]

**6. Reduce the load, on causal-grade evidence.** Mendelian randomisation — the design that uses inherited genetic variation as a natural experiment to separate cause from correlation — found higher BMI causally raises the odds of disc degeneration, back pain and sciatica, at roughly a third higher odds of sciatica per standard-deviation increase in BMI.

[[embed:source:s23]]

## What to skip, and what it costs you to try it anyway

**Bed rest.** Actively worse than staying active. Every day in bed is a day of losing the muscle support that gets you through this.

[[embed:source:s18]]

**Spinal traction.** The Cochrane review of 32 trials found little or no impact on pain, function or return to work, including specifically in people with sciatica. Machines, tables, inversion, and hanging all sit here.

[[embed:source:s20]]

**Repeat scanning a back that is improving.** Your pain resolves on a timescale of weeks; the fragment shrinks over months. A follow-up scan during that window shows you an unchanged herniation while you are actually getting better, and the psychological cost of that image is real.

**Any product claiming to dissolve a herniation.** See Layer 1 above. Nothing has done this in any species in a controlled study.

## Injections buy time, and they may cost you something to do it

Epidural steroid injections produce real short- and medium-term reduction in sciatica pain, with no significant long-term benefit and no change to the underlying natural history.

[[embed:source:s21]]

Understand them for what they are: a bridge across a stretch of pain bad enough to stop you moving, sleeping or working. If the pain is preventing the movement that is the best-evidenced thing you can do, an injection that restores movement is buying something worth having.

Now the tension, stated plainly rather than buried. **Your resorption engine is an inflammatory process.** Suppressing inflammation is the mechanism of both steroids and anti-inflammatory painkillers. In preclinical work corticosteroids inhibited resorption, and a clinical series that deliberately avoided anti-inflammatory drugs reported resorption in every patient.

[[embed:source:s25]]

That is not a reason to refuse a single injection in a crisis. It is a reason to be specific about the difference between a short course and a policy. Weeks of blanket anti-inflammatory suppression as a standing strategy is working against the process clearing your disc. The full argument, with the stomach, kidney and heart numbers attached to it, is here:

[[embed:bpc-157-vs-nsaids]]

## Surgery is faster, not better, at one year — with two things it does not do

The largest randomised evidence is the SPORT trial. Over eight years, both surgical and non-operative patients improved substantially. Surgery delivered faster and greater early relief. It was not a requirement for recovery in most people.

[[embed:source:s9]]

The Dutch trial quoted at the top of this page puts the same finding in one sentence: faster relief with early surgery, identical 95% recovery probability at one year.

[[embed:source:s27]]

Two things surgery does not do:

- **It does not regenerate the disc.** Removing displaced material leaves you with a disc that has less material in it and a tear in the ring.
- **It is not permanent-proof.** Reoperation reached about 15% by eight years in SPORT, roughly 85% of those for a re-herniation at the same level.

[[embed:source:s22]]

Surgery is the right answer for the emergency list at the top, for weakness that is worsening, and for pain that has failed 6 to 12 weeks of genuine conservative care with imaging that matches the symptoms. It is a decision about how long you are willing to hurt, not a decision about whether you will recover.

## Twelve people with a herniated disc, counted

Trials give you averages. Here is what people say happened to them, counted, with the outcomes that did not go well given the same room as the ones that did.

**Denominator: 12 first-person accounts** — 9 from X, 3 from a Reddit thread already filed on this page. **Outcome: 8 resolved or near-resolved, 1 improved but not resolved, 2 still in pain at the time of posting, 1 outcome not stated.** All non-surgical unless stated.

**Resolved — 8 of 12.**

Three years pain-free from a fifteen-minute routine done twice a week:

[[embed:source:s32]]

Eleven months of the worst pain of his life, then near-total resolution on a self-built programme:

[[embed:source:s33]]

Eight months to heal, described without any triumphalism:

[[embed:source:s34]]

A cane at 22, five years of daily pain, told surgery was the only option, and now pain-free:

[[embed:source:s35]]

The long version — years of experimenting, and what finally worked was loaded strength training:

[[embed:source:s36]]

And from Reddit, three accounts on the same thread, including one with a measured reduction on repeat imaging:

[[embed:source:s12]]

[[embed:source:s13]]

[[embed:source:s14]]

**Improved but not resolved — 1 of 12.** Functional in three months, explicitly not back to 100%, and honest about it:

[[embed:source:s37]]

**Still in pain at the time of posting — 2 of 12.**

Third herniation at the same level, thoracic, told surgery is not really an option:

[[embed:source:s38]]

Three weeks in and at the end of her rope — which is exactly what week three of this feels like:

[[embed:source:s39]]

**Outcome not stated — 1 of 12.** Newly diagnosed, told to expect one to three months.

[[embed:source:s40]]

**How much weight to put on that count.** Eight in twelve resolved sits close to the 70% resorption rate and the 95% one-year recovery figure, which is reassuring but partly coincidence: these accounts are heavily selected. People write recovery threads because "did anyone's disc reabsorb?" is a question people search; people in month two of agony often post nothing at all. Note also what the resolved accounts have in common — every one of them describes movement, exercise or physiotherapy, and not one describes a substance. Note the honest one too: @ViktorBunin explicitly says he is not at 100% three months in, which is a more accurate picture of month three than most recovery posts give you.

## Every link, with the strength of the evidence behind it

| Link | Evidence | Strength |
|---|---|---|
| About 70% of herniations reabsorb without surgery | Meta-analysis, 31 studies, 2,233 patients | Strong |
| The more the fragment has broken out, the better it clears | Same meta-analysis, gradient 87.8% → 13.3% | Strong |
| 95% recovered at one year regardless of surgery | Randomised trial, 283 patients | Strong |
| Surgery relieves leg pain faster | Randomised trial + SPORT, 8-year follow-up | Strong |
| Resorption is driven by immune clearance and new blood vessel growth | Mechanistic human and animal studies | Strong |
| Sciatica pain is substantially chemical, not only mechanical | Controlled animal model; enzyme measured 20–100,000× in human discs | Strong |
| Anti-inflammatory suppression can impede resorption | Preclinical inhibition plus one clinical series | Moderate |
| Staying active beats bed rest | Cochrane review | Strong |
| Exercise reduces pain by a clinically important margin | 249 randomised trials, −15.2 points | Strong |
| McKenzie helps the directional-preference subgroup | Randomised trial in responders | Moderate |
| Walking delays the next episode | Randomised trial, 701 people | Moderate |
| Traction helps | Cochrane, 32 trials | Negative |
| Bed rest helps | Cochrane | Negative |
| Epidural steroid gives short-term relief | Meta-analysis | Moderate, temporary |
| Epidural steroid changes the long-term course | Meta-analysis | No effect |
| Higher body weight causally raises sciatica odds | Mendelian randomisation | Strong for cause |
| Smoking accelerates disc degeneration; quitters improve more | Mechanistic plus 5,333-patient cohort | Moderate |
| Any compound reduces physical pressure on the nerve | No study, any species | Absent |
| BPC-157 or TB-500 helps a human disc | No trial, any species, on a disc | Absent |
| ARA-290 improves nerve fibre density and nerve pain | Randomised human trials, small-fibre nerve damage | Moderate, different condition |

## Where the compounds could plausibly act, and where they cannot

Map them onto the four layers and the picture becomes precise instead of promotional.

**Layer 1, physical pressure: nothing.** Time or a surgeon. No exceptions.

**Layer 2, chemical irritation: this is where the mechanistic case sits.** The inflammatory receptor pathway that TNF-alpha runs through is the target of ARA-290, and that compound has actual randomised human trials — for nerve damage rather than for a disc.

[[embed:ara-290]]

**Layer 3, nerve fibre damage.** A severed rat sciatic nerve regrew faster with BPC-157, which is the closest thing to a relevant animal result that exists. It is a rat, it is a cut nerve rather than a compressed one, and no human has been studied.

[[embed:bpc-157]]

**Layer 4, surrounding tissue.** Animal tendon, ligament and muscle repair is where both BPC-157 and TB-500 have the most consistent data — mechanically stronger healed tissue, faster cell migration into poorly supplied tissue.

[[embed:tb-500]]

There is one more thing worth holding onto. Your resorption engine runs on new blood vessel growth, and new blood vessel growth is precisely what these compounds are studied for driving. That could be read as encouraging. It could equally be read as a caution, since nobody has ever tested whether pushing that pathway helps clearance or does something unwanted next to an inflamed nerve. Neither reading is a result. The full mechanism-by-mechanism version, including where each inference breaks, is here:

[[embed:what-are-peptides-herniated-disc]]

And the slower wear process that sets up many herniations in the first place is a separate page with a very different set of numbers:

[[embed:degenerative-disc-disease]]

## What to actually do, this week

1. **Check yourself against the emergency list at the top.** If any of it applies, stop reading and go.
2. **Get out of bed and move within your tolerance.** Not through sharp pain, but not still either.
3. **Find out whether you have a directional preference.** If one direction repeatedly pulls the pain out of your leg and toward your spine, that is a lead worth following with someone who can watch you do it.
4. **Use pain relief to enable movement, in short courses, not as a standing policy.**
5. **Do not book a repeat scan because you still hurt at week six.** Your pain and your imaging are on different clocks.
6. **Count from the start of the episode, not from the day of the scan.** Most of the resorption in that 70% happened inside six months.
7. **Set the surgical decision on a rule, before the bad week arrives:** worsening weakness, or 6 to 12 weeks of genuine conservative effort with pain you cannot live inside, and imaging that matches your symptoms.

*This page explains mechanism and the state of the evidence. It is not a diagnosis, a treatment plan, or medical advice. Red-flag symptoms — bladder or bowel changes, saddle numbness, worsening weakness — are emergencies. The compounds referenced are investigational and unproven for disc conditions.*


## Sources

1. Lumbar Disc Herniation (StatPearls) — https://www.ncbi.nlm.nih.gov/books/NBK560878/
2. Incidence of Spontaneous Resorption of Lumbar Disc Herniation: A Meta-Analysis — https://pubmed.ncbi.nlm.nih.gov/28072796/
3. Systematic review and meta-analysis of predictive factors for spontaneous regression in lumbar disc herniation — https://pubmed.ncbi.nlm.nih.gov/37486886/
4. Prediction and Mechanisms of Spontaneous Resorption in Lumbar Disc Herniation: Narrative Review — https://pmc.ncbi.nlm.nih.gov/articles/PMC11165499/
5. Characteristics and mechanisms of resorption in lumbar disc herniation — https://pmc.ncbi.nlm.nih.gov/articles/PMC9396855/
6. VEGF-induced angiogenesis in herniated disc resorption — https://pubmed.ncbi.nlm.nih.gov/12038611/
7. TNF-alpha in the nucleus pulposus mediates radicular pain in mice — https://pubmed.ncbi.nlm.nih.gov/18670336/
8. High levels of inflammatory phospholipase A2 activity in lumbar disc herniations — https://pubmed.ncbi.nlm.nih.gov/2218714/
9. Surgical vs Nonoperative Treatment for Lumbar Disk Herniation: SPORT Randomized Trial — https://jamanetwork.com/journals/jama/fullarticle/204281
10. Obesity as a Risk Factor for Sciatica: A Meta-Analysis — https://academic.oup.com/aje/article/179/8/929/108237
11. Obesity increases the odds of intervertebral disc herniation and spinal stenosis; an MRI study of 1634 low back pain patients — https://pubmed.ncbi.nlm.nih.gov/38363366/
12. r/Sciatica - herniated disc reabsorption (Alternative-Tomato18) — https://www.reddit.com/r/Sciatica/comments/d3p8jc/has_anyone_had_their_herniated_disc_be/
13. r/Sciatica - herniated disc reabsorption (ame880) — https://www.reddit.com/r/Sciatica/comments/d3p8jc/has_anyone_had_their_herniated_disc_be/
14. r/Sciatica - herniated disc reabsorption (mydiscgotsuckedbacki) — https://www.reddit.com/r/Sciatica/comments/d3p8jc/has_anyone_had_their_herniated_disc_be/
15. The probability of spontaneous regression of lumbar herniated disc: a systematic review — https://pubmed.ncbi.nlm.nih.gov/25009200/
16. Cauda Equina and Conus Medullaris Syndromes (StatPearls) — https://www.ncbi.nlm.nih.gov/books/NBK537200/
17. The natural history of lumbar disc herniation and radiculopathy — https://pubmed.ncbi.nlm.nih.gov/12027305/
18. Bed rest for acute low-back pain and sciatica (Cochrane) — https://pmc.ncbi.nlm.nih.gov/articles/PMC10762886/
19. RCT: McKenzie Method vs Motor Control Exercises in chronic LBP with a directional preference — https://pubmed.ncbi.nlm.nih.gov/27594441/
20. Traction for low-back pain with or without sciatica (Cochrane) — https://pubmed.ncbi.nlm.nih.gov/23959683/
21. Efficacy of epidural steroid injection for sciatica secondary to lumbar disc herniation: meta-analysis — https://pmc.ncbi.nlm.nih.gov/articles/PMC11150834/
22. Surgical vs Non-Operative Treatment for Lumbar Disc Herniation: 8-Year SPORT results — https://pmc.ncbi.nlm.nih.gov/articles/PMC3921966/
23. Causal Associations of Obesity With Disc Degeneration, Low Back Pain, and Sciatica: Mendelian Randomization — https://pmc.ncbi.nlm.nih.gov/articles/PMC8692291/
24. Effects of Tobacco Smoking on the Degeneration of the Intervertebral Disc — https://pmc.ncbi.nlm.nih.gov/articles/PMC4547737/
25. Lumbar Disc Herniation Resorption: When and How Does It Occur? — https://pmc.ncbi.nlm.nih.gov/articles/PMC12890389/
26. Incidence of Spontaneous Resorption of Lumbar Disc Herniation: A Meta-analysis (Clin Spine Surg 2024, PMID 37559207) — https://pubmed.ncbi.nlm.nih.gov/37559207/
27. Surgery versus prolonged conservative treatment for sciatica (NEJM 2007, PMID 17538084) — https://pubmed.ncbi.nlm.nih.gov/17538084/
28. Imaging features of spinal degeneration in asymptomatic populations (AJNR 2015, PMID 25430861) — https://pubmed.ncbi.nlm.nih.gov/25430861/
29. Magnetic resonance imaging of the lumbar spine in people without back pain (NEJM 1994, PMID 8208267) — https://pubmed.ncbi.nlm.nih.gov/8208267/
30. WalkBack: walking and education to prevent low back pain recurrence (Lancet 2024, PMID 38908392) — https://pubmed.ncbi.nlm.nih.gov/38908392/
31. Exercise therapy for chronic low back pain (Cochrane 2021, PMID 34580864) — https://pubmed.ncbi.nlm.nih.gov/34580864/
32. Eight months to fully heal a herniated disc (anecdotal) — https://x.com/SignatiusC/status/2082516526762975377
33. A cane at 22, five years of daily pain, told surgery was the only option, now pain free (anecdotal) — https://x.com/DrRichHuntsman/status/1542510810290827265
34. Years of experimenting, and what finally worked was loaded strength training (anecdotal) — https://x.com/GregPorto/status/1866589329851658629
35. Functional at three months from an L5/S1 herniation, explicitly not at 100% (anecdotal) — https://x.com/ViktorBunin/status/1940473782587552191
36. Third herniation at the same thoracic level, surgery not on the table (anecdotal) — https://x.com/MindlessMuttAD/status/2083679586928255256
37. Week three of a herniated disc, described from inside it (anecdotal) — https://x.com/windupskadi/status/2084644612291842310
38. Newly diagnosed, told one to three months (anecdotal) — https://x.com/Raiyuden_YT/status/1516102705655300103
39. Sciatica from a herniated disc, 95% pain free for three years on a 15-minute routine (anecdotal) — https://x.com/grassfedagent/status/2084101100106338387
40. Eleven months of severe sciatica, then near-total resolution on a self-built programme (anecdotal) — https://x.com/sisto_official/status/1795576275873972340


---

# The Disc Recovery Stack

slug: the-disc-stack · https://miscsubjects.com/a/the-disc-stack · tags: stack, disc, herniated-disc, degenerative-disc-disease, peptides · updated 2026-08-04T20:35:13.192Z

A disc stack is two or more compounds taken at the same time for a worn or bulging spinal disc — most often BPC-157 with TB-500, sometimes with ARA-290 added for the leg pain, sometimes alongside a weight-loss drug. Each compound is aimed at a different step in how a disc fails.

Underneath all of it is one arithmetic. A disc is being broken down at some speed and built back at some other speed, and how your back feels in six months is decided by which of the two is faster. Every single thing on the list below — walking, smoking, a needle, a tablet, a vial — moves one of those two speeds by some amount. What decides your outcome is not any one of those amounts. It is the sum.

That sum is what almost nothing has been measured on. Nobody with a bad disc runs one variable. They are walking or not walking, sleeping six hours or eight, carrying an extra thirty pounds or not, taking ibuprofen daily or not, and injecting one compound or three — all in the same week. The individual numbers below are real and mostly good. The combined numbers, with three exceptions, do not exist, and where they do exist one of them came back negative.

## A worn disc is two speeds, and the slow one is the blood supply

The disc is the largest structure in the body with almost no blood supply of its own. Small vessels reach the outermost fibres of the tough outer ring and stop there; the soft centre is fed by fluid seeping through the bone above and below it. Every repair process in the body runs on blood delivery, so the disc rebuilds more slowly than any other load-bearing tissue you own.

[[embed:source:s1]]

That does not mean the rebuild side loses. Pooled across eleven cohort studies of people managed without surgery, 66.66% of herniated discs shrank on their own (95% CI 51% to 69%). In the United Kingdom subset the figure was 82.94%; in the Japanese subset, 62.58%.

[[embed:source:s2]]

The shrinking is done by immune cells that treat the displaced fragment as foreign material, digest it, and bring new blood vessels in behind them to carry the debris away.

[[embed:source:s3]]

Two things follow from that pair of facts, and they set up everything else. First, the rebuild side already wins about two times in three with nobody doing anything. Second, the mechanism it wins by is inflammation plus new blood vessel growth — which is precisely the mechanism a daily anti-inflammatory tablet is designed to shut down.

[[embed:degenerative-disc-disease]]

## Genetics puts a number on each thing that wears a disc down

Observational studies of back pain are badly confounded: people who smoke also move less, weigh more and sleep worse, so an association tells you almost nothing about direction. Mendelian randomisation gets around that by using inherited gene variants as the exposure — you are assigned your variants at conception, before any lifestyle exists, so the arrow can only point one way.

A 2026 synthesis pooled twenty such studies in people against disc degeneration and put an odds ratio on each factor. An odds ratio of 1.26 means roughly a 26% higher chance of the outcome per unit of the exposure.

| What moves the breakdown speed | Odds of disc degeneration | How to move it |
|---|---|---|
| Time spent sitting watching television | 1.78 (1.52–2.08) | Stand up and walk; this is the largest lifestyle number in the set |
| Body mass index | 1.26 (1.14–1.38) | Weight loss by any route |
| Waist circumference | 1.26 (1.04–1.53) | Same lever, measured at the belly |
| Smoking, ever having started | 1.22 (1.12–1.33) | Stopping — with a caveat below |
| Triglycerides in the blood | 1.08 (1.03–1.13) | Diet, weight loss, movement |
| Type 2 diabetes | 1.05 (1.03–1.07) | Glucose control |
| Higher bone density | 1.20 (1.15–1.25) | Not a lever — you would not lower it on purpose |

[[embed:source:s8]]

The body-mass row has a second, condition-specific measurement behind it. A meta-analysis of observational studies in people found overweight raised the odds of nerve-root leg pain by 1.23 and obesity by 1.40 — the same direction as the genetic estimate, in the exact symptom most people with a disc actually have.

[[embed:source:s4]]

Read the television row again, because it is the one nobody talks about. Genetically predicted television time carried a larger effect on disc degeneration than smoking, weight, blood fats and diabetes. Sitting still is the biggest modifiable factor in the whole causal set.

On stopping smoking, the honest answer has a limit in it. Rats exposed to cigarette smoke for eight weeks developed cracked, torn, misaligned outer rings and fibrous tissue in the soft centre. After they stopped, the degeneration stopped getting worse and the soft centre regained some of its gel-like material. The physical misalignment of the outer ring did not come back, and the inflammatory signal IL-1beta was still raised eight weeks after the last cigarette.

[[embed:source:s17]]

So stopping smoking halts the slide and buys back part of the chemistry, and does not undo the structural damage already done. That distinction — halting versus reversing — applies to almost every item on this page.

Two more entries on the breakdown side, both self-inflicted by treatment rather than by lifestyle.

Repeated steroid injections into the spine cost bone. Three thousand injected patients were compared with three thousand matched controls; each successive injection raised the risk of a vertebral fracture by a factor of 1.21 (95% CI 1.08 to 1.30). One injection is a small bill. A course of six is a compounding one.

[[embed:source:s14]]

Months of daily anti-inflammatories buy less pain relief than most people assume and work against the clearance mechanism described above. Pooled across 32 trials and 5,356 people with acute back pain, the drugs beat placebo by 7.29 points on a 0–100 pain scale — a difference the Cochrane reviewers called small and probably not clinically relevant.

[[embed:source:s21]]

[[embed:bpc-157-vs-nsaids]]

## Walking is the only item on this page with a hazard ratio behind it

WalkBack randomised 701 Australian adults who had just recovered from a back pain episode into either an individualised, progressive walking programme with six physiotherapist sessions over six months, or no treatment at all. The walking group went a median 208 days before their next activity-limiting episode (95% CI 149–295). The control group went 112 days (89–140). The hazard ratio was 0.72 (95% CI 0.60–0.85, p=0.0002) — meaning that at any given moment, a walker's chance of the pain returning was 28% lower.

[[embed:source:s7]]

Two details in that trial matter for anyone assembling a combination. It cost AU$7,802 per quality-adjusted life-year, which made it cost-effective with 94% probability. And it was not free of harm: lower-limb adverse events ran 100 in the walking group against 54 in the control group.

For pain that is already chronic rather than recurring, structured exercise pooled across 249 randomised trials in people produced roughly a 15-point improvement on a 0–100 scale against no treatment or usual care — about double what an anti-inflammatory delivers for acute pain, and roughly five times what one delivers for chronic pain.

[[embed:source:s10]]

That is the whole evidence-based core of a disc recovery plan, and it is walking and loading. Everything else on this page is added on top of it, and nothing else on this page has a number that comes close.

## Three things sold as the raw material for the rebuild were tested and did nothing

The intuition that a rebuilding tissue needs feeding is reasonable. The intuition has been tested three times and lost three times, and a page that skipped that would be selling something.

Collagen. Thirty-nine recreationally active men took either 15 g of collagen peptides daily or a placebo through 15 weeks of supervised lower-body resistance training. Both groups gained tendon stiffness (+17.3% collagen, +20.9% placebo) and Young's modulus (+17.8% versus +20.6%). Between the groups, nothing: no difference on any tendon measure, with p-values between 0.365 and 0.877. The training built the tendon. The powder added nothing detectable.

[[embed:source:s12]]

Vitamin D. Ten randomised trials in people with chronic low back pain, pooled: standardised mean difference −0.130 (95% CI −0.260 to 0.000), which touches zero. Long-term dosing did not help either, and neither did the active forms. Baseline vitamin D status made no difference to the result.

[[embed:source:s13]]

Weight loss on its own, once exercise is already in place. Across 22 trials and 3,602 people, weight-loss interventions beat minimal care on pain (SMD −0.54) — but head to head against exercise alone, in four trials and 673 people, weight loss was no better (SMD −0.13, 95% CI −0.40 to 0.14). The credibility of the whole body of evidence was rated very low.

[[embed:source:s11]]

That last result is a compounding finding, not a single-factor one, and it is the first of only three real interaction measurements on this entire page. Weight loss and exercise are not additive in the way the arithmetic of the two-speeds model would suggest. They overlap. Buying both does not buy you twice.

## Each peptide is aimed at a different step, and none has been put near a disc

BPC-157 is a fifteen-amino-acid chain based on a sequence found in human stomach fluid. In rats it raises VEGF, the signal that grows new blood vessels into damaged tissue, and drives connective-tissue cells to move into an injury and rebuild it. A cut rat Achilles tendon treated with it came back mechanically stronger than an untreated one.

[[embed:bpc-157]]

TB-500 is a seven-amino-acid fragment of a larger natural protein, thymosin beta-4. In animals it acts on cell movement and on the organisation of collagen laid down in a healing wound. The molecule in the vial and the molecule in most of the published research are not the same thing, which is covered in full on its own page.

[[embed:tb-500]]

The reason a nerve compound is in a disc stack at all is that a large share of the pain is chemical rather than mechanical. Material leaking from a torn disc releases TNF-alpha and IL-1beta onto the nerve root, and those two signals are the ones tied to both the ongoing breakdown of the disc and the pain itself.

[[embed:source:s5]]

ARA-290 is the only one of the three with randomised human evidence of any kind. In a 28-day phase 2b trial, 64 people with sarcoidosis-related small nerve fibre loss and nerve pain took 1, 4 or 8 mg a day or placebo. At 4 mg the corneal nerve fibre area rose by 697 µm² over placebo (95% CI 159–1,236, p=0.012), and regenerating skin nerve fibres rose too (p=0.035). Pain improved in every group including placebo; the placebo-corrected pain difference in the moderate-to-severe subgroup did not reach significance (p=0.157).

[[embed:source:s16]]

[[embed:ara-290]]

Read that carefully, because it is the strongest human result any compound in this stack has, and it is about a nerve in an eye of a person with sarcoidosis. Nobody has run ARA-290 against a nerve root squeezed by a disc. Human evidence in one tissue and one disease does not transfer to another by argument.

Retatrutide is not a disc compound at all. It is a weight-loss drug, and its only relevance here runs through the body-mass row of the table above: less load on the column, no direct action on disc tissue.

[[embed:retatrutide]]

[[embed:what-are-peptides-herniated-disc]]

## The one experiment that tested the pair found no bonus for taking both

This is the single most important result on this page, and it is the one that the phrase "the repair pair" was invented before anybody had.

In 2026, 32 male Sprague-Dawley rats, each about 330 g, had their Achilles tendon cut and repaired, then were split into four groups of eight: control, BPC-157 at 10 µg/kg/day, TB-500 at 60 µg/kg/day, and both together. Everything was injected into the belly, daily, for four weeks.

Results, arm by arm:

| Arm | Load to failure | Tissue architecture score | Verdict |
|---|---|---|---|
| Control | baseline | baseline | — |
| BPC-157 alone | higher, not statistically significant | numerically better, not significant | signal without proof |
| TB-500 alone | higher, significant (p<0.05) | Bonar p=0.016, Movin p=0.017 | the only arm that moved the mechanical number |
| Both together | not significantly better than either alone | Movin p=0.040 | no bonus for the second compound |

The authors' own sentence: "Combined BPC-157 and TB-500 treatment did not confer additional benefits compared to either agent alone."

[[embed:source:s9]]

Their proposed explanation is that the two compounds converge on the same downstream machinery, so the second one has nothing left to add. They flag it as a hypothesis needing confirmation.

Now negate it properly, because a single result does not settle a question in either direction. Eight rats per arm is small. An additive effect of, say, 15% would very likely be missed at that sample size. The endpoint was a tendon at four weeks, not a disc at six months. The route was into the belly, which is not how anybody takes either compound. And no dose-response work was done, so a different ratio of the two might behave differently. What the experiment establishes is narrow and real: at these doses, in this tissue, on these endpoints, the pair did not beat the better single compound. What it does not establish is that combining them is pointless everywhere.

The claim it does damage to is specific. Anyone who tells you the two compounds are synergistic is describing a mechanism, not a measurement. The measurement exists, it was taken in 2026, and it came back flat.

## Six real combinations, side by side

Nobody chooses one row of the tables above. They choose a whole column of behaviour. Here are six combinations a person with a bad disc actually ends up in, with what is known about each part, what is known about the parts in combination, and where the interaction has never been measured.

| The combination | What each part is measured at, alone | What is measured about the combination | Never measured |
|---|---|---|---|
| **A. Walking 25 min/day + adequate protein + BPC-157 + TB-500** | Walking: hazard ratio 0.72, 701 people, HUMAN. Protein/collagen: no tendon effect over placebo in 39 men, HUMAN. BPC-157: rat tendon repair, ANIMAL. TB-500: rat tendon repair, ANIMAL | The two peptides together: no benefit beyond either alone in 32 rats, ANIMAL | Walking with either peptide, in any species. Any of it in a human disc |
| **B. Smoking + no movement + repeated steroid injections + daily anti-inflammatories** | Smoking: odds 1.22, HUMAN. Sitting: odds 1.78, HUMAN. Each steroid injection: 1.21× fracture risk, HUMAN. Anti-inflammatories: 7.29/100 points of pain relief and suppression of the clearance mechanism, HUMAN | Nothing. Not one study has combined these four | Everything. This is the most common real-world combination and the least studied |
| **C. Walking alone, nothing else changed** | Hazard ratio 0.72 for recurrence; ~15/100 points for chronic pain across 249 trials, HUMAN | This is the measured baseline every other row should be compared against | — |
| **D. Both peptides, no change to movement or weight** | Rat tendon data only, ANIMAL | The pair, in rats: no additive benefit, ANIMAL | Whether peptides do anything at all when the load driving the damage is unchanged |
| **E. Weight loss on a GLP-1 drug + walking, no peptides** | Weight: odds 1.26 per unit of body mass index, HUMAN. Walking: hazard ratio 0.72, HUMAN | Weight loss versus exercise alone, head to head: no added benefit, 4 trials, 673 people, HUMAN | Retatrutide specifically — a 586-person trial is running and reports in 2027 |
| **F. Everything: walking + weight loss + BPC-157 + TB-500 + ARA-290** | Each part as above; ARA-290 has 64-person HUMAN data in a different disease | Nothing whatsoever | The entire combination. No study in any species has given three of these compounds together |

Read column three. Across six combinations, the total measured interaction evidence is three findings: weight loss adds nothing on top of exercise in people, the two peptides add nothing on top of each other in rats, and nothing else has been looked at.

## The interactions nobody has measured, written down so the holes are visible

Naming a gap is a finding. These are the specific pairs and triples that a person assembling a stack is implicitly betting on, with no measurement behind them:

- BPC-157 combined with any form of exercise, in any species.
- Either peptide combined with an anti-inflammatory drug — which matters, because the drug suppresses the same new-blood-vessel step the peptide is proposed to drive. Rats given BPC-157 alongside diclofenac had less gut damage, but nobody measured the tendon.
- ARA-290 combined with either of the other two, in any species.
- Any of the three during active shrinking of a herniation, where the body's own immune clean-up is already running.
- Weight loss combined with either peptide.
- All three peptides together, which is what the popular stack actually is.
- Any of it against the 66.66% background rate of the disc fixing itself. This is the sharpest hole: without a control arm, a person who improves on a stack cannot tell whether the stack did it or whether they were in the two-thirds.

## Every claim above, against the thing that would break it

A claim counts as established only after it has survived its own negation. Here is each substantive claim on this page put against what would falsify it, and whether that test has been run.

| Claim | Tier | What would break it | Has that been tested? |
|---|---|---|---|
| Most herniations shrink without treatment | HUMAN | A cohort where imaging shows no change in most people | Tested repeatedly; 11 cohorts pooled at 66.66% |
| Walking lowers the recurrence rate | HUMAN | A randomised trial where the walking arm relapses as fast as controls | Tested; 701 people; walking arm went 96 days longer |
| Sitting is the largest modifiable driver of degeneration | HUMAN | A causal-genetic study putting television time below smoking or weight | Tested in 20 pooled studies; television time came out highest at 1.78 |
| Supplying raw material speeds tissue rebuilding | HUMAN | A trial where collagen plus training beats training alone | Tested; 39 men, 15 weeks, no between-group difference |
| Vitamin D helps chronic back pain | HUMAN | A pooled result whose confidence interval excludes zero | Tested; 10 trials; interval touches zero |
| Weight loss adds to exercise | HUMAN | A head-to-head trial where the combined arm beats exercise alone | Tested; 4 trials, 673 people; no added benefit |
| BPC-157 and TB-500 are synergistic | ANIMAL | An experiment where the combined arm beats both single arms | Tested once, 2026, 32 rats: the combined arm did not beat either alone |
| BPC-157 rebuilds tendon | ANIMAL | Rat tendons treated with it failing at the same load as controls | Tested; treated tendons failed at higher loads; never tested in a person |
| ARA-290 regrows nerve fibres | HUMAN | A randomised trial where nerve fibre area does not rise over placebo | Tested; rose 697 µm² over placebo at 4 mg, p=0.012, in sarcoidosis |
| ARA-290 relieves nerve pain from a squeezed nerve root | — | Any randomised trial in that population | Never run. This claim is untested, not supported |
| Any peptide here changes a human disc | — | An imaging trial with a placebo arm | Never run in any species |
| Repeated steroid injections are consequence-free | HUMAN | A matched cohort showing no rise in fracture risk with injection count | Tested; each injection multiplied fracture risk by 1.21 |
| Sleep matters to how a disc feels | HUMAN | A crossover trial where cutting sleep does not change pain thresholds | Tested; 39 volunteers; cutting sleep by 40% raised pain sensitivity, with no change in inflammatory blood markers |

[[embed:source:s15]]

One row deserves adding, because it is the only human evidence that a degenerated disc responds to anything regenerative at all. Pooled across trials of stem cell injection into painful degenerated discs, pain and disability scores improved — small studies, early, and the only positive human regeneration signal that exists for this tissue.

[[embed:source:s6]]

The three rows with no tier are the honest edge of this subject. They are not weak evidence. They are absence of evidence, and they sit in a table rather than in the headline because eleven of the fourteen rows above them have real numbers.

[[embed:herniated-disc]]

## Fifteen people who ran a combination, counted

**Fifteen first-person accounts on X, all self-reported, none verified, none from any trial. Ten of them ran two or more compounds together for a spine problem, and five ran BPC-157 on its own. One further account reports harm from the pair at a different site.**

**Of the ten who stacked, seven reported it helped, two reported partial benefit, and one reported none.**

Three weeks on the pair after an L4-L5 herniation, back on a basketball court against two months last time:

[[embed:source:s22]]

A 2017 L4/L5/S1 herniation with a degeneration diagnosis, and this person says he was pain-free within a month on the pair:

[[embed:source:s23]]

ARA-290 plus BPC-157 plus TB-500 for one month after spine surgery, with the sciatica reported 95% gone:

[[embed:source:s24]]

Lower spine degeneration, barely able to stand upright, and this person reports being pain-free on the pair and still dosing:

[[embed:source:s25]]

Retatrutide alongside a BPC-157/TB-500 blend, low back reported much improved — the only account here combining a weight-loss drug with the peptides:

[[embed:source:s27]]

Three compounds at once for severe back pain, reported cleared in three to four weeks:

[[embed:source:s28]]

Severe leg pain, reported 75% better the same evening and gone by day three:

[[embed:source:s30]]

**Partial — 2 of 10.** One month of the pair for lifelong back pain: recovery between flares got faster, and the pain is still there.

[[embed:source:s26]]

Six weeks of the pair for a dried-out lowest disc: biceps and shoulder pain gone, the disc itself only partly better and still needing physiotherapy.

[[embed:source:s29]]

**No benefit — 1 of 10.** One person ran the pair alongside a second stack for joint damage and called the whole thing a waste of money.

[[embed:source:s31]]

**Of the five who ran a single compound, one reported it helped, three reported nothing, and one reported that one compound did nothing for him while a different one worked.**

L5/S1 herniation, BPC-157 alone and deliberately unpaired, 90% pain reduction in two weeks:

[[embed:source:s33]]

The same compound healing a wrist and doing nothing for the same person's disc:

[[embed:source:s34]]

A week of it to avoid neck surgery; the surgery happened anyway:

[[embed:source:s35]]

Oral capsules taken instead of injections, and no help for a back:

[[embed:source:s37]]

One compound nothing for a back injury, the other clearing it in five days — which is the closest thing in this entire set to a within-person comparison, and it points at the two compounds not being interchangeable:

[[embed:source:s36]]

**Harm — 1 report.** Two months of the pair for knees brought slight improvement in the joints, along with badly disrupted sleep and lowered heart-rate variability. Both the sleep and the heart-rate variability went back to normal after stopping.

[[embed:source:s32]]

**What fifteen accounts settle, and what they cannot.** They cannot compare the stack against a single compound, even though the numbers above look like they do. The stacked group reported a better outcome rate than the single-compound group — 7 of 10 against 1 of 5 — and that difference is worthless as evidence. People who buy three vials have spent more, expect more, and are more likely to post a result. People who describe a null outcome tend to be answering somebody else's thread rather than writing their own. And every single one of these people is running against a background rate where two thirds of herniations resolve regardless.

What the accounts do settle is narrower and still worth having. The reported experience is not uniformly positive: four of fifteen describe no benefit for a spine, and one describes a genuine harm. Timelines that people report cluster at two to six weeks, which is faster than any animal tendon study would predict and is exactly the window in which spontaneous shrinking also happens. Nobody in this set reported a serious adverse event.

## Two registry entries that would move a row each, and a third that is only a template

Two entries on ClinicalTrials.gov are marked recruiting and would each convert one row of the tables above from mechanism into measurement. Neither of them is a disc. A third entry is listed below because it circulates as though it were a trial, and it is not one.

| Registry ID | What it tests | Size | Primary endpoint | Reports |
|---|---|---|---|---|
| NCT07035093 | Retatrutide in people with obesity or overweight and chronic low back pain, phase 3, Eli Lilly | 586 | Pain intensity and body weight change, to 72 weeks | Estimated September 2027 |
| NCT07437547 | BPC-157 for acute hamstring strain, phase 2, Hudson Biotech | 120 | Days to unrestricted sport, and MRI injury volume at day 14 under blinded central review | Estimated February 2027 |
| NCT07487363 | Not a trial. A record that declares itself a fictional example, written in the style of a TB-500 study of cardiovascular markers in stable arterial disease, phase 1/2, Hudson Biotech | 80, stated inside the example | Treatment-emergent adverse events at 12 weeks, stated inside the example | Nothing will ever report |

Read the third row against its own record before counting it. The public summary of NCT07487363 opens: "This fictional study is an example of a ClinicalTrials.gov-style record." Its dose field says the levels "are not provided in this public example." It is a demonstration template, and any page citing it as proof that TB-500 is being tested in people is citing a placeholder. Its sponsor, Hudson Biotech, filed eight entries of that shape between 2 and 15 February 2026, one of which is the BPC-157 hamstring entry in the row above it.

[[embed:source:s18]]

[[embed:source:s19]]

[[embed:source:s20]]

The BPC-157 hamstring trial is the one worth watching, because MRI injury volume under blinded review is the first objective tissue measurement of this compound in a person. If it comes back flat, the entire rat literature stops transferring. If it comes back positive, the disc question becomes worth running rather than worth arguing about.

## What holds always, what holds never, and what depends on something

**Foundational — true with everything else stripped away.** The disc has almost no blood supply and rebuilds slowly. Immune cells and new blood vessels are what remove a herniated fragment. Load, weight, sitting time, smoking and blood sugar act on the breakdown speed. Movement acts on the rebuild speed. BPC-157 and TB-500 are proposed to act on the rebuild speed by improving blood vessel growth and connective tissue repair. ARA-290 acts on nerve fibres, not on the disc.

**Always true.** Two out of three herniations shrink without treatment, so any uncontrolled personal result is uninterpretable. Every steroid injection adds fracture risk in proportion to the count. Any claim about a peptide in a human disc rests on zero measurements in any species.

**Never true.** No compound named on this page is an approved medicine for a disc anywhere in the world. No published experiment has found a bonus from combining BPC-157 with TB-500 — the one experiment that tested it found none. No trial has combined a peptide with exercise, with weight loss, or with an anti-inflammatory.

**Conditional, with the dependency named.** Walking lowers recurrence risk by 28% — in adults who have recently recovered from an episode, over six months of a progressive programme with physiotherapist contact, not in someone in acute pain today. Stopping smoking halts further degeneration and partly restores the gel in the soft centre — in rats, over eight weeks, and it does not reverse the structural misalignment. ARA-290 regrows nerve fibres — in 64 people with sarcoidosis, at 4 mg a day for 28 days, measured in the cornea. BPC-157 strengthens a healing tendon — in rats, injected into the belly, at 10 µg/kg/day, measured at four weeks. TB-500 improves tendon architecture and load to failure — in rats, at 60 µg/kg/day, on the same schedule. Weight loss reduces back pain — against minimal care, and not against exercise.

Red-flag symptoms are the exception to everything above and are not a matter of weighing evidence: loss of bladder or bowel control, numbness across the area that would contact a saddle, or weakness that is getting worse are emergencies and need a hospital the same day. Nothing on this page is a dose, a schedule or a recommendation to take anything, and every compound named is unapproved for disc disease. TB-500 and BPC-157 are both banned in tested sport at all times.


## Sources

1. Discogenic Low Back Pain: Anatomy, Pathophysiology and Treatments of Intervertebral Disc Degeneration — https://pmc.ncbi.nlm.nih.gov/articles/PMC9820240/
2. Incidence of Spontaneous Resorption of Lumbar Disc Herniation: A Meta-Analysis — https://pubmed.ncbi.nlm.nih.gov/28072796/
3. Characteristics and mechanisms of resorption in lumbar disc herniation — https://pmc.ncbi.nlm.nih.gov/articles/PMC9396855/
4. Obesity as a Risk Factor for Sciatica: A Meta-Analysis — https://academic.oup.com/aje/article/179/8/929/108237
5. Disc in Flames: Roles of TNF-alpha and IL-1beta in Intervertebral Disc Degeneration — https://pmc.ncbi.nlm.nih.gov/articles/PMC4751407/
6. Mesenchymal stem cells can improve discogenic pain in patients with IVD degeneration: a meta-analysis — https://pmc.ncbi.nlm.nih.gov/articles/PMC10313064/
7. WalkBack: individualised progressive walking to prevent low back pain recurrence — randomised trial, 701 adults (Lancet 2024, PMID 38908392) — https://pubmed.ncbi.nlm.nih.gov/38908392/
8. Causal links between multi-domain risk factors and disc degeneration: meta-analysis of 20 Mendelian randomization studies (BMC Musculoskelet Disord 2026, PMID 42243749) — https://pubmed.ncbi.nlm.nih.gov/42243749/
9. BPC-157, TB-500 and the two together on rat Achilles healing — 32 rats, 8 per arm (Jt Dis Relat Surg 2026, PMID 42542926) — https://pubmed.ncbi.nlm.nih.gov/42542926/
10. Exercise therapy for chronic low back pain (Cochrane 2021, 249 trials, PMID 34580864) — https://pubmed.ncbi.nlm.nih.gov/34580864/
11. Weight-loss interventions for pain and disability in musculoskeletal disorders — 22 trials, 3,602 participants (JOSPT 2020, PMID 32272032) — https://pubmed.ncbi.nlm.nih.gov/32272032/
12. 15 g/day collagen peptides plus 15 weeks of resistance training, 39 men — tendon outcomes (Med Sci Sports Exerc 2023, PMID 37436929) — https://pubmed.ncbi.nlm.nih.gov/37436929/
13. Vitamin D supplementation for chronic low back pain — 10 randomised trials (In Vivo 2024, PMID 39477425) — https://pubmed.ncbi.nlm.nih.gov/39477425/
14. Vertebral body fractures after lumbar epidural steroid injections — 3,000 injected vs 3,000 propensity-matched controls (JBJS Am 2013, PMID 23780532) — https://pubmed.ncbi.nlm.nih.gov/23780532/
15. Partial-night sleep restriction and pain sensitivity — 39 healthy volunteers, crossover (Scand J Pain 2025, PMID 41021423) — https://pubmed.ncbi.nlm.nih.gov/41021423/
16. Cibinetide (ARA-290) phase 2b in sarcoidosis-associated small nerve fibre loss — 64 people, 28 days (IOVS 2017, PMID 28475703) — https://pubmed.ncbi.nlm.nih.gov/28475703/
17. Rat discs after 8 weeks of smoke exposure and after stopping (J Orthop Sci 2006, PMID 16568393) — https://pubmed.ncbi.nlm.nih.gov/16568393/
18. NCT07035093 — retatrutide in people with obesity or overweight and chronic low back pain, phase 3, 586 participants (Eli Lilly) — https://clinicaltrials.gov/study/NCT07035093
19. NCT07437547 — BPC-157 for acute hamstring muscle strain, phase 2, 120 participants (Hudson Biotech) — https://clinicaltrials.gov/study/NCT07437547
20. NCT07487363 — a record that declares itself a fictional example, written in the style of a TB-500 (thymosin beta-4 17-23 fragment) study of cardiovascular biomarkers in stable atherosclerotic disease, phase 1/2, 80 participants (Hudson Biotech) — https://clinicaltrials.gov/study/NCT07487363
21. Anti-inflammatory drugs for acute low back pain — 32 trials, 5,356 participants (Cochrane 2020, PMID 32297973) — https://pubmed.ncbi.nlm.nih.gov/32297973/
22. Herniated L4-L5, three weeks on BPC-157 with TB-500, back on the court (anecdotal, X, 2026-07-28) — https://x.com/thebillyboone/status/2082100039707427193
23. Severe L4/L5/S1 herniation and a degeneration diagnosis, pain-free within a month on the pair (anecdotal, X, 2026-07-26) — https://x.com/jasonsvoboda/status/2081426443024961838
24. ARA-290 plus BPC-157 plus TB-500 for one month after back surgery, sciatica reported 95% gone (anecdotal, X, 2026-07-25) — https://x.com/cryptorayray89/status/2081141222719045707
25. Lower spine degeneration, reported pain-free on BPC-157 with TB-500, still dosing (anecdotal, X, 2026-07-25) — https://x.com/KateinMB/status/2080854619593363787
26. One month of the pair for lifelong back pain — recovery faster, pain still present (anecdotal, X, 2026-07-23) — https://x.com/BrandBarons/status/2080279766796562881
27. Retatrutide alongside a BPC-157/TB-500 blend, low back reported improved (anecdotal, X, 2026-07-08) — https://x.com/yakyusenshu23/status/2074846700674674986
28. Three compounds at once for back pain, cleared in three to four weeks (anecdotal, X, 2026-06-03) — https://x.com/mannyjplays/status/2062148959976526143
29. Six weeks of the pair — shoulder and biceps resolved, the disc only partly (anecdotal, X, 2026-07-31) — https://x.com/MuroCrypto/status/2083184469956059529
30. Severe leg pain, reported gone over three days on BPC-157 with TB-500 (anecdotal, X, 2026-08-02) — https://x.com/L0V3lsKeY/status/2083868515438666186
31. The pair called a waste of money for joint damage (anecdotal, X, 2026-05-21) — https://x.com/jakew/status/2057454035855094005
32. Two months of the pair for knees — slight improvement, sleep and heart-rate variability disrupted until stopping (anecdotal, X, 2026-07-28) — https://x.com/franchupardo/status/2082241971582579132
33. L5/S1 herniation, BPC-157 alone and deliberately unpaired, 90% pain reduction in two weeks (anecdotal, X, 2026-07-23) — https://x.com/NewsAsset/status/2080378902984458706
34. BPC-157 worked on a wrist and did nothing for the same person's herniated disc (anecdotal, X, 2026-05-18) — https://x.com/derek_j_scv/status/2056494210963107983
35. A week of BPC-157 to avoid neck surgery, surgery happened anyway (anecdotal, X, 2026-04-30) — https://x.com/NICKELL11b/status/2049997364883030236
36. One of the two did nothing for a back injury, the other cleared it in five days (anecdotal, X, 2026-04-12) — https://x.com/PeptideRookie/status/2043371104731910313
37. Oral BPC-157 capsules did not help a back problem (anecdotal, X, 2026-03-01) — https://x.com/AhaSahhDude/status/2027919309620609260